Comparing dry eye disease in adult and paediatric populations via the IRIS Registry

Article

Almost 5 million patients in the IRIS Registry had received at least one diagnosis of DED between 2013 and 2019; of those, 203,171 were children under 18 years of age and 4,592,808 were adults.

Comparing dry eye disease in adult and paediatric populations via the IRIS Registry

A study of dry eye disease (DED) in children found that the average age of onset of DED is at 12.51 years compared with the average of 61.06 years in adults. The highest prevalence in children was seen between 12 to 15 years of age, according to lead author Dr Vivian Paraskevi Douglas, DVM, MBA, MSc, and colleagues from Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, United States.

Although DED is highly prevalent in adults, with rates ranging from 5% to 50%, little is known about the disorder in paediatric patients, which sparked the interest in this study.

IRIS Registry data

The investigators used the extensive data in the American Academy of Ophthalmology IRIS® (Intelligent Research in Sight) Registry to study the difference between the paediatric and adult populations.

Almost 5 million patients in the IRIS Registry had received at least one diagnosis of DED between 2013 and 2019; of those, 203,171 were children under 18 years of age and 4,592,808 were adults.

Dr Douglas and associates collected data on biologic sex, race, ethnicity, and US geographic region of residence.

The data breakdown showed that DED was diagnosed in females significantly more often compared with males. More cases of DED were diagnosed among white adults and children compared with Asian and Black/African American patients; more cases were diagnosed among non-Hispanic and Latino children and adults compared with Hispanic/Latino patients, and more cases were diagnosed in patients in both age groups in the North Central and Northeast regions of the US.

Among the paediatric patients, DED had higher prevalence rates in those with refractive errors and eyelid/conjunctival disorders, the authors reported.

Regarding seasons, springtime had the highest prevalence of DED and winter the lowest among the paediatric population.

“Until recently, paediatric dry eye disease has been an under-recognized disease due to diagnostic limitations and challenges of interpreting the symptoms in children. We are excited about the potential for big data to provide insight that informs our care for this segment of the population,” Dr Douglas and mentor Dr Aisha Traish concluded.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.